Erythropoietin

INDICATIONS

FDA

  • Anemia secondary to chronic renal failure.
  • Anemia secondary to AZT and low erythropoietin levels in HIV-infected pts.
  • Anemia secondary to chemotherapy.
  • Reduction of allogenic blood transfusion in pts with significant blood loss during surgery.

NON-FDA APPROVED USES

  • Anemia without correctable cause in HIV-infected pts w/ low erythropoietin levels (< 500 IU/L).

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: September 29, 2018